These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24847863)

  • 1. Pemetrexed induces S-phase arrest and apoptosis via a deregulated activation of Akt signaling pathway.
    Chen KC; Yang TY; Wu CC; Cheng CC; Hsu SL; Hung HW; Chen JW; Chang GC
    PLoS One; 2014; 9(5):e97888. PubMed ID: 24847863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained activation of ERK and Cdk2/cyclin-A signaling pathway by pemetrexed leading to S-phase arrest and apoptosis in human non-small cell lung cancer A549 cells.
    Yang TY; Chang GC; Chen KC; Hung HW; Hsu KH; Sheu GT; Hsu SL
    Eur J Pharmacol; 2011 Aug; 663(1-3):17-26. PubMed ID: 21575631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol 3-kinase/Akt positively regulates Fas (CD95)-mediated apoptosis in epidermal Cl41 cells.
    Lu B; Wang L; Stehlik C; Medan D; Huang C; Hu S; Chen F; Shi X; Rojanasakul Y
    J Immunol; 2006 Jun; 176(11):6785-93. PubMed ID: 16709838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells.
    Tu YS; Kang XL; Zhou JG; Lv XF; Tang YB; Guan YY
    Eur J Pharmacol; 2011 Nov; 670(2-3):356-64. PubMed ID: 21958871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Akt-mediated HDAC3 expression and CDK2 T39 phosphorylation by a bichalcone analog contributes to S phase retardation of cancer cells.
    Hung KC; Lin ML; Hsu SW; Lee CC; Huang RY; Wu TS; Chen SS
    Eur J Pharmacol; 2018 Jun; 829():141-150. PubMed ID: 29665367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways.
    Yang TY; Chang GC; Chen KC; Hung HW; Hsu KH; Wu CH; Sheu GT; Hsu SL
    Mol Carcinog; 2013 Mar; 52(3):183-94. PubMed ID: 22086658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells.
    Giovannetti E; Lemos C; Tekle C; Smid K; Nannizzi S; Rodriguez JA; Ricciardi S; Danesi R; Giaccone G; Peters GJ
    Mol Pharmacol; 2008 Apr; 73(4):1290-300. PubMed ID: 18187583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF
    Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.
    Wu M; Yuan Y; Pan YY; Zhang Y
    Mol Med Rep; 2014 Aug; 10(2):931-8. PubMed ID: 24840891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
    Sakurikar N; Thompson R; Montano R; Eastman A
    Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pemetrexed induces G1 phase arrest and apoptosis through inhibiting Akt activation in human non small lung cancer cell line A549.
    Wu DM; Zhang P; Xu GC; Tong AP; Zhou C; Lang JY; Wang CT
    Asian Pac J Cancer Prev; 2015; 16(4):1507-13. PubMed ID: 25743822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.
    Yang ZP; Zhao Y; Huang F; Chen J; Yao YH; Li J; Wu XN
    World J Gastroenterol; 2015 Sep; 21(36):10385-99. PubMed ID: 26420965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardized Saponin Extract from Baiye No.1 Tea (
    Tu Y; Chen L; Ren N; Li B; Wu Y; Rankin GO; Rojanasakul Y; Wang Y; Chen YC
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32752095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galangin Induces p53-independent S-phase Arrest and Apoptosis in Human Nasopharyngeal Carcinoma Cells Through Inhibiting PI3K-AKT Signaling Pathway.
    Lee CC; Lin ML; Meng M; Chen SS
    Anticancer Res; 2018 Mar; 38(3):1377-1389. PubMed ID: 29491062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of the pemetrexed-activated MAPK pathway via sorafenib is involved in the synergistic mechanism of sorafenib subsequent potentiation of pemetrexed cytotoxicity in EGFR TKI-resistant cell lines.
    Jiang Y; Li C; Ma Y; Chen J; Li Y; Chen L
    Clin Lab; 2012; 58(5-6):551-61. PubMed ID: 22783588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of AKT sensitizes chemoresistant ovarian cancer cells to cisplatin by abrogating S and G2/M arrest.
    Zhang D; Piao HL; Li YH; Qiu Q; Li DJ; Du MR; Tsang BK
    Exp Mol Pathol; 2016 Jun; 100(3):506-13. PubMed ID: 27163202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
    Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
    Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway.
    Ming P; Cai T; Li J; Ning Y; Xie S; Tao T; Tang F
    Oncotarget; 2016 Jul; 7(27):41843-41856. PubMed ID: 27259234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells.
    Yan J; Zhong N; Liu G; Chen K; Liu X; Su L; Singhal S
    Cell Death Dis; 2014 Jul; 5(7):e1316. PubMed ID: 24991768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.